If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jan 2021 11:22

RNS Number : 2245N
InnovaDerma PLC
28 January 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

InnovaDerma plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Type 1 Disclosure as per the Transparency Directive II Regulation

3. Details of person subject to the notification obligationiv

Name

Octopus Investments Nominees Limited

City and country of registered office (if applicable)

33 Holborn, London, EC1N 2HT

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

26/01/2021

6. Date on which issuer notified (DD/MM/YYYY):

27/01/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.308%

N/A

4.308%

17,393,633

Position of previous notification (if

applicable)

0.000%

N/A

0.000%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BT9PTW34

749,385

4.308%

SUBTOTAL 8. A

749,385

4.308%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Octopus Capital Ltd

Octopus Investments Ltd

Octopus Investments Nominees Ltd

4.308%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information N/A

 

Place of completion

33 Holborn, London, EC1N 2HT

Date of completion

27/01/2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBBGDBBDDDGBI
Date   Source Headline
5th May 20172:05 pmRNSSecond Price Monitoring Extn
5th May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20172:06 pmRNSSecond Price Monitoring Extn
3rd May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20177:15 amRNSCompany update and Directorate Change
2nd May 20177:00 amRNSAcquisition
28th Apr 20178:05 amRNSBroker Warrants
11th Apr 20177:00 amRNSAllotment of Shares
3rd Apr 20177:00 amRNSTrading update
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
3rd Mar 20172:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20172:00 pmRNSPrice Monitoring Extension
2nd Mar 201711:18 amRNSExercise of Share Options
1st Mar 20177:00 amRNSCompletion of Acquisitions
27th Feb 20177:00 amRNSAcquisition of Stevie K and Charles + Lee Brands
9th Feb 20177:00 amRNSHalf-year Report
30th Jan 20177:00 amRNSDirectorate Change
27th Jan 201711:17 amRNSNotice of Results
25th Jan 20178:00 amRNSHeads of Agreement with PROS Korea
16th Jan 20177:00 amRNSTrading Statement
10th Jan 20177:00 amRNSDirectorate Change
9th Jan 20179:06 amRNSSecond Price Monitoring Extn
9th Jan 20179:00 amRNSPrice Monitoring Extension
19th Dec 20163:18 pmRNSHolding(s) in Company
15th Dec 201610:08 amRNSResult of AGM
14th Dec 20169:45 amRNSPlacing
8th Dec 20167:00 amRNSCompletion of Placing
6th Dec 20167:30 amRNSGeneral Manager appointed for the UK and Europe
25th Nov 20167:00 amRNSPlacing and Fundraising
17th Nov 20164:34 pmRNSNotice of AGM & Posting of Annual Report
16th Nov 20161:54 pmRNSBroker Warrants
14th Nov 20167:00 amRNSPublication of Supplementary Prospectus
11th Nov 201611:23 amRNSDirector/PDMR Shareholding
31st Oct 201610:25 amRNSFinal Results
31st Oct 20167:00 amRNSInnovaDerma enters US market
24th Oct 20167:00 amRNSOperational update & presentation published online
21st Oct 20162:15 pmRNSIssue of Equity
20th Oct 201611:05 amRNSSecond Price Monitoring Extn
20th Oct 201611:00 amRNSPrice Monitoring Extension
10th Oct 20167:00 amRNSTrading Statement
9th Sep 201612:38 pmRNSVoluntary Suspension of Trading on Marche Libre
7th Sep 20167:00 amRNSAdmission to the Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.